LMR Partners’s Q32 Bio QTTB Stock Holding History

LMR Partners’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-831	Closed	-$24K	–	1299
2022 Q3	$24K	Hold	831	–	–	﹤0.01%	1149
2022 Q2	$29K	Buy	+831	New	+$28.4K	﹤0.01%	1211

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

LMR Partners's QTTB Position: Q4 2022 in Review

LMR Partners sold out of Q32 Bio (QTTB) in Q4 2022, closing a stake of 831 shares — an estimated $24K sold.

LMR Partners first reported a position in QTTB in Q2 2022 and held it in 2 quarters. The position peaked at $29K in Q2 2022. 79 funds tracked by Wall St. Rank hold QTTB as of Q4 2022.

LMR Partners reported no remaining Q32 Bio position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 831 Q32 Bio shares in Q4 2022, an estimated $24K.
LMR Partners first reported a position in Q32 Bio in Q2 2022 and held it in 2 quarters.
LMR Partners's Q32 Bio position peaked at $29K in Q2 2022.
79 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.